DYRK1A and Dravet syndrome: 2011; Park and Chung 2013; Duchon and Herault 2016; Antonarakis 2017). In addition, several reports have described potential Dyrk1a inhibitors and their possible use for correcting DS‐related deficits (de la Torre and Dierssen 2012; Becker et al. 2014; Duchon and Herault 2016).